Loading clinical trials...
Loading clinical trials...
The primary objective of the rollover study is to evaluate the long-term safety of avapritinib in participants who have completed a Blueprint Medicines sponsored study (parent study) and continued to ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Blueprint Medicines Corporation
Universitair Ziekenhuis Antwerpen (UZA)
Edegem
The Hospital for Sick Children
Toronto, Ontario
A.O.U. San Giovanni di Dio e Ruggi d'Aragona di Salerno
Salerno
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions